Prosecution Insights
Last updated: October 26, 2026
Application No. 19/220,641

BIOLOGICAL INFORMATION OUTPUT DEVICE

Non-Final OA §102§103
Filed
May 28, 2025
Priority
Nov 29, 2022 — JP 2022-190488 +1 more
Examiner
CASILLASHERNANDEZ, OMAR
Art Unit
2689
Tech Center
2600 — Communications
Assignee
Murata Manufacturing Co., Ltd.
OA Round
1 (Non-Final)
77%
Grant Probability
Favorable
1-2
OA Rounds
8m
Est. Remaining
94%
With Interview

Examiner Intelligence

Grants 77% — above average
77%
Career Allowance Rate
501 granted / 652 resolved
+14.8% vs TC avg
Strong +17% interview lift
Without
With
+17.4%
Interview Lift
resolved cases with interview
Fast prosecutor
2y 1m
Avg Prosecution
23 currently pending
Career history
679
Total Applications
across all art units

Statute-Specific Performance

§101
2.6%
-37.4% vs TC avg
§103
53.2%
+13.2% vs TC avg
§102
19.0%
-21.0% vs TC avg
§112
16.8%
-23.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 652 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim status This action is in response to applicant filed on 05/28/2025. Claims 1-11 are pending for examination. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim(s) 1-3, 5 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Oyama (US 2019/0286207). Regarding claim 1: Oyama disclose a biological information output device comprising: a controller that controls running and stopping of the biological information output device which runs on power supply from a battery and which outputs biological information (¶0035-0036 & ¶0042), wherein the controller is configured to: acquire an initial battery level which is a level of the battery at a start of the running of the biological information output device (¶0071: an initial battery level must be determined in order to calculate remaining power ), determine whether the initial battery level is less than or equal to a first level, the first level being a level required for the biological information output device to run for a preset time (¶0075-0076: “NO” answer to question in S1113), and when it is determined that the initial battery level is less than or equal to the first level, output a notification signal that notifies a user that the running will not continue for the preset time (Fig. 6-7, ¶0077). Regarding claim 2: Oyama disclose the biological information output device according to claim 1, wherein the controller is further configured to: after outputting the notification signal, end the running of the biological information output device running on the power supply of the battery (Fig. 6-7, ¶0077). Regarding claim 3: Oyama disclose the biological information output device according to claim 1, wherein the controller is further configured to: acquire a current level of the battery, during running of the biological information output device, determine whether the current level is less than or equal to a second level, the second level being less than the first level, and output a warning signal that notifies the user when it is determined that the current level is less than or equal to the second level.(¶0095) Regarding claim 5: Oyama disclose the biological information output device according to claim 3, wherein, when the current level is less than or equal to the first level and greater than the second level, the controller is configured to continue running the biological information output device.(¶0095) Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 4, 6-7 is/are rejected under 35 U.S.C. 103 as being unpatentable over Oyama (US 2019/0286207) in view of Yamashita (US 2019/0117081). Regarding claim 4: Oyama disclose the biological information output device according to claim 3, but does not explicitly disclose wherein the controller is further configured to: after outputting the warning signal, end the running of the biological information output device running on power supply from the battery. In analogous art regarding battery management in a biological information output device, Yanmashita disclose a biological information output device that after outputting the warning signal, end the running of the biological information output device running on power supply from the battery.(¶0074) Before the effective filing date, it would have been obvious to the one of the ordinary skill in the art to include the features of after outputting the warning signal, end the running of the biological information output device running on power supply from the battery, as disclose by Yamashita, to the system of Oyama. The motivation is to save power. Regarding claim 6: Oyama disclose the biological information output device according to claim 1, but does not explicitly disclose wherein the controller is further configured to: acquire a continuous running time since start of the battery-powered running, and when the continuous running time is longer than or equal to the preset time, output a signal that notifies the user that power required for running for the preset time is consumed. In analogous art regarding battery management in a biological information output device, Yamashita disclose wherein the controller is further configured to: acquire a continuous running time since start of the battery-powered running, and when the continuous running time is longer than or equal to the preset time, output a signal that notifies the user that power required for running for the preset time is consumed.(Fig. 3, ¶0044-0052) Before the effective filing date, it would have been obvious to the one of the ordinary skill in the art to include the features of wherein the controller is further configured to: acquire a continuous running time since start of the battery-powered running, and when the continuous running time is longer than or equal to the preset time, output a signal that notifies the user that power required for running for the preset time is consumed, as disclose by Yamashita, to the system of Oyama. The motivation is to save power. Regarding claim 7: The combination of Oyama and Yamashita disclose the biological information output device according to claim 6, wherein the controller is further configured to: after outputting the signal, end the running of the biological information output device running on power supply from the battery. (Yamashita: Fig. 3, ¶0044-0052) Claim(s) 8 is/are rejected under 35 U.S.C. 103 as being unpatentable over Oyama (US 2019/0286207) in view of Makinouchi et al. (US 2017/0215029) Regarding claim 8: Oyama disclose the biological information output device according to claim 1, but does not explicitly disclose wherein the controller is further configured to: acquire, through wireless communication, the biological information from a biosensor. In analogous art regarding biological information output device, Makinouchi disclose a biological information output device configured to: acquire, through wireless communication, the biological information from a biosensor.(¶0037) Before the effective filing date, it would have been obvious to the one of the ordinary skill in the art to include the feature of wherein the controller is further configured to: acquire, through wireless communication, the biological information from a biosensor, as disclose by Makinouchi, to the system of Oyama. The motivation is to provide mobility and communication range. Allowable Subject Matter Claims 9-11 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Conclusion The prior art made of record cited in the PTO-892 and not relied upon is considered pertinent to applicant's disclosure. Any inquiry concerning this communication or earlier communications from the examiner should be directed to OMAR CASILLASHERNANDEZ whose telephone number is (571)270-5432. The examiner can normally be reached Monday-Friday, 8:30AM-4:30PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Davetta Goins can be reached at (571) 272-2957. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /OMAR CASILLASHERNANDEZ/ Primary Examiner, Art Unit 2689
Read full office action

Prosecution Timeline

May 28, 2025
Application Filed
Sep 28, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12764918
RFID CONVERSION INSTALLATION AND CONTROL METHOD FOR A PLURALITY OF INLAY DISPENSING MODULES
2y 7m to grant Granted Oct 13, 2026
Patent 12761199
LOW-LATENCY WIRELESS COMMUNICATION DEVICE AND PROTOCOL FOR CO2 BOT SENSING COMMUNICATION
2y 2m to grant Granted Oct 13, 2026
Patent 12748459
WRISTBAND DEVICE FOR ENHANCED AUDIENCE ENGAGEMENT AT LIVE EVENTS
2y 2m to grant Granted Sep 29, 2026
Patent 12738134
NAVIGABLE 3D VIEW OF A PREMISES ALARM EVENT
1y 8m to grant Granted Sep 15, 2026
Patent 12731001
SYSTEMS AND METHODS FOR TAG-BASED DIAGNOSTIC CHAIN OF CUSTODY MANAGEMENT
2y 8m to grant Granted Sep 08, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
77%
Grant Probability
94%
With Interview (+17.4%)
2y 1m (~8m remaining)
Median Time to Grant
Low
PTA Risk
Based on 652 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month